Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

UCD participants were significantly younger, had lower waist circumference and blood pressure and had significantly higher vitamin D concentrations compared to participants at the UU centre.Baseline characteristics of treatment groupsDemographic variableGroupP valuePlaceboActive(n 40)(n 41): Age (years)65.2 (8.4)64.7 (6.3)0.784Sex n male (female)17 (23)16 (25): Weight (kg)73.0 (63.4 to 84.0)72.8 (63.3 to 84.2)0.916Height (m)1.69 (0.09)1.68 (0.08)0.587BMI (kg/m2)25.5 (23.5 to 29.5)25.4 (23.4 to 29.5)0.860Waist (cm)92.70 (82.63 to 102.50)89.75 (81.50 to 105.05)0.702Hip (cm)104.28 (8.56)104.42 (8.74)0.944Waist:hip0.89 (0.09)0.90 (0.10)0.605Systolic BP (mmHg)130.9 (19.7)127.6 (20.3)0.469Diastolic BP (mmHg)76.2 (8.6)74.6 (10.1)0.321Plasma total 25(OH)D (nmol/L)62.5 (22.4)59.3 (25.2)0.539Serum Homocysteine (µmol/L)11.05 (9.68 to 12.75)11.86 (10.29 to 15.05)0.047Serum folate (nmol/L)18.0 (14.3 to 21.9)15.5 (11.8 to 21.6)0.123Serum vitamin B12 (pmol/L)336 (235 to 449)310 (246 to 409)0.357Plasma PLP (vitamin B6; nmol/L)61.7 (48.6 to 85.1)59.4 (44.5 to 74.1)0.487Riboflavin (EGRac)1.29 (1.24 to 1.35)1.34 (1.25 to 1.43)0.168Data presented as mean (SD) and median (IQR).

Source: Supplementation with B vitamin drinks for 16 weeks improved B-vitamin status. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Randomised controlled trial.

Randomised controlled trial

Assigns participants or groups to comparison interventions by chance.

Meta-analysis unclear · Double-blind reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A double-blinded randomised controlled trial was performed in parallel at University College Dublin and Ulster University.

Source: Abstract.

A double-blinded randomised controlled trial was performed in parallel at University College Dublin and Ulster University.

Source: Abstract.

Participants aged > 50 years were recruited following screening for exclusion criteria (i.e.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Effectiveness of a fortified drink in improving B vitamin biomarkers in older adults: a controlled intervention trial

Randomised controlled trial · Nutrition & Metabolism · 2021

Original publication title

Effectiveness of a fortified drink in improving B vitamin biomarkers in older adults: a controlled intervention trial

Maria Heffernan; Leanne C. Doherty; Roberta Hack Mendes; Michelle Clarke; Stephanie Hodge; Michelle Clements; Liadhan McAnena; Mari Rivelsrud; Mary Ward; J. J. Strain; Helene McNulty; Lorraine Brennan

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The results demonstrate that a B vitamin-fortified drink was effective in optimising B vitamin status, making this a useful intervention option to improve B vitamin status in older adults.

Trial registration ISRCTN, ISRCTN61709781: Retrospectively registered, https://www.isrctn.com/ISRCTN61709781

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Older adults are reported to have sub-optimal B vitamin status; targeted food-based solutions may help to address this. The objectives of the OptiAge food intervention study were to develop and investigate the effectiveness of a B vitamin-fortified drink in improving B vitamin biomarkers in older Irish adults with a primary outcome of change in the B vitamin biomarker status.

Source: Background

Abstract: What methods does the paper describe?

A double-blinded randomised controlled trial was performed in parallel at University College Dublin and Ulster University. Participants aged > 50 years were recruited following screening for exclusion criteria (i.e. taking medications known to interfere with B vitamin metabolism, supplements containing B vitamins, consuming > 4 portions of B vitamin-fortified foods per week or diagnosed with gastrointestinal, liver or pulmonary disease). Recruited participants meeting the inclusion criteria were randomised (by sex and study centre) to receive daily for 16 weeks either B vitamin-fortified or placebo drinks as developed by Smartfish, Norway.

Each B vitamin-fortified drink (200 ml) contained 200 µg folic acid, 10 µg vitamin B12, 10 mg vitamin B6 and 5 mg riboflavin, while the placebo was an identical, isocaloric formulation without added B vitamins. Fasting blood samples were collected pre: and post-intervention which were used to measure the primary outcome of change in B vitamin biomarker levels.

Source: Methods

Abstract: Results

A total of 95 participants were randomised, of which 81 commenced the trial. Of these, 70 completed (37 in the active and 33 in the placebo groups). Intention to treat (ITT) analysis of the B vitamins demonstrated a significant improvement in all B vitamin biomarkers in the active compared to placebo groups: p < 0.01 for each of serum folate, serum vitamin B12 and plasma pyridoxal 5′-phosphate (vitamin B6) and the functional riboflavin biomarker, erythrocyte glutathione reductase activation coefficient (EGRac).

Correspondingly, a significant lowering of serum homocysteine from 11.9 (10.3 to 15.1) µmol/L to 10.6 (9.4 to 13.0) µmol/L was observed in response to the active treatment (P < 0.001). Similar results were seen in a per-protocol analysis.

Source: Results

Abstract: Conclusions

The results demonstrate that a B vitamin-fortified drink was effective in optimising B vitamin status, making this a useful intervention option to improve B vitamin status in older adults.

Trial registration ISRCTN, ISRCTN61709781: Retrospectively registered, https://www.isrctn.com/ISRCTN61709781

Source: Conclusions Source: Conclusions
Authors’ abstract

Background

Older adults are reported to have sub-optimal B vitamin status; targeted food-based solutions may help to address this. The objectives of the OptiAge food intervention study were to develop and investigate the effectiveness of a B vitamin-fortified drink in improving B vitamin biomarkers in older Irish adults with a primary outcome of change in the B vitamin biomarker status.

Methods

A double-blinded randomised controlled trial was performed in parallel at University College Dublin and Ulster University. Participants aged > 50 years were recruited following screening for exclusion criteria (i.e. taking medications known to interfere with B vitamin metabolism, supplements containing B vitamins, consuming > 4 portions of B vitamin-fortified foods per week or diagnosed with gastrointestinal, liver or pulmonary disease). Recruited participants meeting the inclusion criteria were randomised (by sex and study centre) to receive daily for 16 weeks either B vitamin-fortified or placebo drinks as developed by Smartfish, Norway.

Each B vitamin-fortified drink (200 ml) contained 200 µg folic acid, 10 µg vitamin B12, 10 mg vitamin B6 and 5 mg riboflavin, while the placebo was an identical, isocaloric formulation without added B vitamins. Fasting blood samples were collected pre: and post-intervention which were used to measure the primary outcome of change in B vitamin biomarker levels.

Results

A total of 95 participants were randomised, of which 81 commenced the trial. Of these, 70 completed (37 in the active and 33 in the placebo groups). Intention to treat (ITT) analysis of the B vitamins demonstrated a significant improvement in all B vitamin biomarkers in the active compared to placebo groups: p < 0.01 for each of serum folate, serum vitamin B12 and plasma pyridoxal 5′-phosphate (vitamin B6) and the functional riboflavin biomarker, erythrocyte glutathione reductase activation coefficient (EGRac).

Correspondingly, a significant lowering of serum homocysteine from 11.9 (10.3 to 15.1) µmol/L to 10.6 (9.4 to 13.0) µmol/L was observed in response to the active treatment (P < 0.001). Similar results were seen in a per-protocol analysis.

Conclusions

The results demonstrate that a B vitamin-fortified drink was effective in optimising B vitamin status, making this a useful intervention option to improve B vitamin status in older adults.

Trial registration ISRCTN, ISRCTN61709781: Retrospectively registered, https://www.isrctn.com/ISRCTN61709781

Supplementary Information

The online version contains supplementary material available at 10.1186/s12986-021-00630-8.

Publication and source details

Original title: Effectiveness of a fortified drink in improving B vitamin biomarkers in older adults: a controlled intervention trial

Maria Heffernan; Leanne C. Doherty; Roberta Hack Mendes; Michelle Clarke; Stephanie Hodge; Michelle Clements; Liadhan McAnena; Mari Rivelsrud; Mary Ward; J. J. Strain; Helene McNulty; Lorraine Brennan

Nutrition & Metabolism · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.department of agriculture, food and the marine15F685Brennan Lorraine

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T08:05:46.778378+00:00

DOI: 10.1186/s12986-021-00630-8 · PMC8650259